New perspectives on the basal forebrain cholinergic system in Alzheimer's disease

Neurosci Biobehav Rev. 2023 Jul:150:105192. doi: 10.1016/j.neubiorev.2023.105192. Epub 2023 Apr 20.

Abstract

The basal forebrain cholinergic system (BFCS) has long been implicated in age-related cognitive changes and the pathophysiology of Alzheimer's disease (AD). Limitations of cholinergic interventions helped to inspire a shift away from BFCS in AD research. A resurgence in interest in the BFCS following methodological and analytical advances has resulted in a call for the BFCS to be examined in novel frameworks. We outline the basic structure and function of the BFCS, its role in supporting cognitive and affective function, and its vulnerability to aging and AD. We consider the BFCS in the context of the amyloid hypothesis and evolving concepts in AD research: resilience and resistance to pathology, selective neuronal vulnerability, trans-synaptic pathology spread and sleep health. We highlight 1) the potential role of the BFCS in cognitive resilience, 2) recent work refining understanding about the selective vulnerability of BFCS to AD, 3) BFCS connectivity that suggests it is related to tau spreading and neurodegeneration and 4) the gap between BFCS involvement in AD and sleep-wake cycles.

Keywords: Acetylcholine; Amyloid; Attention; Basal forebrain; Learning; Memory; Reserve; Resilience; Tau.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aging
  • Alzheimer Disease* / pathology
  • Basal Forebrain*
  • Cholinergic Agents
  • Humans
  • Sleep

Substances

  • Cholinergic Agents